Package | gov.healthit.ecqi.ecqms |
Resource Type | Measure |
Id | CMS104FHIRSTKDCAntithrombotic |
FHIR Version | R4 |
Source | http://ecqi.healthit.gov/ecqms/https://build.fhir.org/ig/cqframework/ecqm-content-qicore-2025/Measure-CMS104FHIRSTKDCAntithrombotic.html |
URL | https://madie.cms.gov/Measure/CMS104FHIRSTKDCAntithrombotic |
Version | 0.9.003 |
Status | active |
Date | 2025-06-20T21:30:13+00:00 |
Name | CMS104FHIRSTKDCAntithrombotic |
Title | Discharged on Antithrombotic TherapyFHIR |
Description | Ischemic stroke patients prescribed or continuing to take antithrombotic therapy at hospital discharge |
Copyright | Measure specifications are in the Public Domain LOINC(R) copyright 2004-2024 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2024 International Health Terminology Standards Development Organisation. ICD-10 copyright 2024 World Health Organization. All Rights Reserved. |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Metadata | |
---|---|
Title | Discharged on Antithrombotic TherapyFHIR |
Version | 0.9.003 |
Short Name | CMS104FHIR |
GUID (Version Independent) | urn:uuid:4f57e4a2-097b-45f8-9c85-91b35ea92dc1 |
GUID (Version Specific) | urn:uuid:3e24cf04-e7a8-4f7d-b9bc-3c3e3b1b39b6 |
CMS Identifier | 104FHIR |
Effective Period | 2026-01-01 through 2026-12-31 |
Steward (Publisher) | The Joint Commission |
Developer | The Joint Commission |
Description | Ischemic stroke patients prescribed or continuing to take antithrombotic therapy at hospital discharge |
Copyright | Measure specifications are in the Public Domain LOINC(R) copyright 2004-2024 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2024 International Health Terminology Standards Development Organisation. ICD-10 copyright 2024 World Health Organization. All Rights Reserved. |
Disclaimer | These performance measures are not clinical guidelines, do not establish a standard of medical care, and have not been tested for all potential applications. The measures and specifications are provided without warranty. |
Rationale | The effectiveness of antithrombotic agents in reducing stroke mortality, stroke-related morbidity and recurrence rates has been studied in several large clinical trials. While the use of these agents for patients with acute ischemic stroke and transient ischemic attacks continues to be the subject of study, substantial evidence is available from completed studies. Data at this time suggest that antithrombotic therapy should be prescribed at discharge following acute ischemic stroke to reduce stroke mortality and morbidity if no contraindications exist. For patients with a stroke due to a cardioembolic source (e.g., atrial fibrillation, mechanical heart valve), warfarin is recommended unless contraindicated. In recent years, novel oral anticoagulant agents (NOACs) have been developed and approved by the U.S. Food and Drug Administration (FDA) for stroke prevention and may be considered as an alternative to warfarin for select patients. Anticoagulation therapy is not generally recommended for secondary stroke prevention in patients presumed to have a non-cardioembolic stroke Anticoagulants at doses to prevent venous thromboembolism are insufficient antithrombotic therapy to prevent recurrent ischemic stroke or transient ischemic attack (TIA). |
Clinical Recommendation Statement | Clinical trial results suggest that antithrombotic therapy should be prescribed at discharge following acute ischemic stroke to reduce stroke mortality and morbidity if no contraindications exist |
Citation |
CITATION - Adams, H., Adams, R., del Zoppo, G., et al. (2005, April). Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update—A scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke, 36(4): 916-923. |
Citation |
CITATION - Adams, H. P., Jr., del Zoppo, G., Alberts, M. J., et al. (2007, May). Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke, 38(5), 1655-1711. |
Citation |
CITATION - Albers, G. W, Amarenco, P., Easton, J. D., et al. (2001). Antithrombotic and thrombolytic therapy for ischemic stroke. Chest, 119, 300-320. |
Citation |
CITATION - Albers, G. W., Amarenco, P., Easton, J. D., et al. (2004, September). Antithrombotic and thrombolytic therapy for ischemic stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126(3), 483S-512S. |
Citation |
CITATION - Antiplatelet Trialists’ Collaboration. (1994, January 8). Collaborative overview of randomised trials of antiplatelet therapy—I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ, 308(6921), 81-106. |
Citation |
CITATION - Antithrombotic Trialists’ Collaboration. (2002, January 12). Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ, 324(7329), 71-86. |
Citation |
CITATION - Bhatt, D. L., Fox, K. A., Hacke, W., et al. (2006, April 20). Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. New England Journal of Medicine, 354(16), 1706-1717. |
Citation |
CITATION - Brott, T. G., Clark, W. M., Fagan, S. C., et al. (2000). Stroke: The first hours. Guidelines for acute treatment. Washington, DC: National Stroke Association. |
Citation |
CITATION - Canadian Cooperative Study Group. (1978, July 13). A randomized trial of aspirin and sulfinpyrazone in threatened stroke. New England Journal of Medicine, 299(2), 53-59. |
Citation |
CITATION - CAPRIE Steering Committee. (1996, November 16). A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 348(9038), 1329-1339. |
Citation |
CITATION - Centers for Disease Control and Prevention. (2009, May 1). Prevalence and most common causes of disability among adults—United States, 2005. Morbidity and Mortality Weekly Report, 58(16), 421-426. |
Citation |
CITATION - Chen, Z. M., Sandercock, P., Pan, H. C., et al. (2000, June). Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40,000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke, 31(6), 1240-1249. |
Citation |
CITATION - Coull, B. M., Williams, L. S., Goldstein, L. B., et al. (2002, July). Anticoagulants and antiplatelet agents in acute ischemic stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association). Stroke, 33(7), 1934-1942. |
Citation |
CITATION - Diener, H. C., Bogousslavsky, J., Brass, L. M., et al. (2004, July). Aspirin and lopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial. Lancet, 364(9431), 331-337. |
Citation |
CITATION - Dutch Tia Trial Study Group. (1991, October 31). A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. New England Journal of Medicine, 325(18), 1261-1266. |
Citation |
CITATION - Eccles, M., Freemantle, N., & Mason, J. (1998, April 25). North of England Evidence-Based Guideline Development Project: Guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. BMJ, 316(7140), 1303-1309. |
Citation |
CITATION - ESPRIT Study Group, Halkes, P. H., van Gijn, J., et al. (2006, May 20). Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomised controlled trial. Lancet, 367(9523), 1665-1673. |
Citation |
CITATION - ESPS Group. (1987, December 12). The European Stroke Prevention Study (ESPS): Principal end-points. Lancet, 2(8572), 1351-1354. |
Citation |
CITATION - Farrell, B., Godwin, J., Richards, S., et al. (1991, December). The United Kingdom Transient Ischaemic Attack (Uk-Tia) Aspirin Trial: Final results. Journal of Neurology, Neurosurgery, and Psychiatry, 54(12), 1044-1054. |
Citation |
CITATION - Gaspoz, J. M., Coxson, P. G., Goldman, P. A., et al. (2002, June 6). Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. New England Journal of Medicine, 346(23), 1800-1806. |
Citation |
CITATION - Gent, M., Blakely, J. A., Easton, J. D., et al. (1989, June 3). The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1(8649), 1215-1220. |
Citation |
CITATION - Gorelick, P. B., Richardson, D., Kelly, M., et al. (2003, June 11). Aspirin and ticlopidine for prevention of recurrent stroke in black patients: A randomized trial. JAMA, 289(22), 2947-2957. |
Citation |
CITATION - Guyatt, G. H., Akl, E. A., Crowther, M., et al. (2012, February). Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 141(2 Suppl.), 7S-47S. |
Citation |
CITATION - Guyatt, G., Schunemann, H., Cook, D., et al. (2001, January). Grades of recommendation for antithrombotic agents. Chest, 119(1 Suppl.), 3S-7S. |
Citation |
CITATION - Hass, W. K., Easton, J. D., Adams, H. P., Jr., et al. (1989, August 24). Randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. New England Journal of Medicine, 321(8), 501-507. |
Citation |
CITATION - International Stroke Trial Collaborative Group. (1997, May 31). The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet, 349(9065), 1569-1581. |
Citation |
CITATION - Jauch, E. C., Saver, J. L., Adams, H. P., Jr., et al. (2013). Guidelines for the early management of patients with acute ischemic stroke: A guideline for health care professionals from the American Heart Association/American Stroke Association. Stroke, 44(3), 870-947. |
Citation |
CITATION - Johnson, E. S., Lanes, S. F., Wentworth, C. E., III, et al. (1999, June 14). A metaregression analysis of the dose-response effect of aspirin on stroke. Archives of Internal Medicine, 159(11), 1248-1253. |
Citation |
CITATION - Kennedy, J., Hill, M. D., Ryckborst, K. J., et al. (2007, November). Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): A randomised controlled pilot trial. Lancet Neurology, 6(11): 961-969. |
Citation |
CITATION - Kernan, W. N., Ovbiagele, B., Black, H. R., et al. (2014, May). Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for health care professionals from the American Heart Association/American Stroke Association. Stroke, 45(7), 2160-2223. |
Citation |
CITATION - Powers, W. J., Rabinstein, A. A., Ackerson, T., et al. (2018, January). 2018 guidelines for the early management of patients with acute ischemic stroke: A guideline for health care professionals from the American Heart Association/American Stroke Association. Stroke, 49, e45-e46. |
Citation |
CITATION - Roger, V. L., Go, A. S., Lloyd-Jones, D. M., et al. (2012, January 3). Heart disease and stroke statistics—2012 update: A report from the American Heart Association. Circulation, 125(1), e2-e220. |
Citation |
CITATION - Sacco, R. L., Diener, H. C., Yusuf, S., et al. (2008, September 18). Aspirin and Extended-Release Dipyridamole Versus Clopidogrel for Recurrent Stroke. New England Journal of Medicine, 359(12), 1238-1251. |
Citation |
CITATION - SALT Collaborative Group. (1991, November 30). Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet, 338(8779), 1345-1349. |
Citation |
CITATION - UK-Tia Study Group. (1988, January 30). United Kingdom Transient Ischaemic Attack (UK-Tia) Aspirin Trial: Interim results. British Medical Journal (Clinical Research Ed.), 296(6618), 316-320. |
Citation |
CITATION - Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., ... Williams, L. S. (2021). 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline from the American Heart Association/American Stroke Association. Stroke, 52(7), e364-e467. https://doi.org/10.1161/STR.0000000000000375 |
Guidance (Usage) | The "Nonelective Inpatient Encounter" value set intends to capture all non-scheduled hospitalizations. This value set is a subset of the "Inpatient encounter" value set, excluding concepts that specifically refer to elective hospital admissions. Non-elective admissions include emergency, urgent and unplanned admissions. The "Medication, Discharge" datatype refers to the discharge medication list and is intended to express medications ordered for post-discharge use. The denominator population includes patients with inpatient hospitalizations and patients from Acute Hospital Care at Home programs, who are treated and billed as inpatients but receive care in their home. This dQM is an episode-based measure. An episode is defined as each inpatient hospitalization or encounter that ends during the measurement period. This FHIR-based measure has been derived from the QDM-based measure: CMS104v14. Please refer to the HL7 QI-Core Implementation Guide (https://hl7.org/fhir/us/qicore/STU6/) for more information on QI-Core and mapping recommendations from QDM to QI-Core STU 6. (https://hl7.org/fhir/us/qicore/STU6/qdm-to-qicore.html). |
Measure Group (Rate) (ID: Group_1) | |
Summary | Ischemic stroke patients prescribed or continuing to take antithrombotic therapy at hospital discharge |
Basis | Encounter |
Scoring | Proportion |
Type | Process |
Rate Aggregation | None |
Improvement Notation | Increased score indicates improvement |
Initial Population |
ID: InitialPopulation_1
Description: Inpatient hospitalizations (non-elective admissions) for patients age 18 and older, discharged from inpatient care with a principal diagnosis of ischemic stroke, ending during the measurement period Logic Definition: Initial Population |
Denominator |
ID: Denominator_1
Description: Equals Initial Population Logic Definition: Denominator |
Denominator Exclusion |
ID: DenominatorExclusion_1
Description: - Inpatient hospitalizations for patients admitted for elective carotid intervention. This exclusion is implicitly modeled by only including non-elective hospitalizations. - Inpatient hospitalizations for patients discharged to another hospital - Inpatient hospitalizations for patients who left against medical advice - Inpatient hospitalizations for patients who expired - Inpatient hospitalizations for patients discharged to home for hospice care - Inpatient hospitalizations for patients discharged to a health care facility for hospice care - Inpatient hospitalizations for patients with comfort measures documented Logic Definition: Denominator Exclusions |
Numerator |
ID: Numerator_1
Description: Inpatient hospitalizations for patients prescribed or continuing to take antithrombotic therapy at hospital discharge Logic Definition: Numerator |
Denominator Exception |
ID: DenominatorException_1
Description: - Inpatient hospitalizations for patients with a documented reason for not prescribing antithrombotic therapy at discharge - Inpatient hospitalizations for patients who receive Prasugrel as an antithrombotic therapy at discharge Logic Definition: Denominator Exceptions |
Supplemental Data Guidance | For every patient evaluated by this measure also identify payer, race, ethnicity and sex; SDE Ethnicity-Patient's Ethnicity: Hispanic or Latino Not Hispanic or Latino SDE Payer-Patient's Payer: Categories of types of health care payer entities as defined by the US Public Health Data Consortium SOP code system SDE Race-Patient's Race: Native Hawaiian or Other Pacific Islander Asian American Indian or Alaska Native Other Race White Black or African American SDE Sex-Patient's Sex: Gender identity restricted to only Male and Female used in administrative situations requiring a restriction to these two categories. |
Supplemental Data Elements | |
Supplemental Data Element |
ID: sde-ethnicity
Usage Code: Supplemental Data Description: SDE Ethnicity Logic Definition: SDE Ethnicity |
Supplemental Data Element |
ID: sde-payer
Usage Code: Supplemental Data Description: SDE Payer Logic Definition: SDE Payer |
Supplemental Data Element |
ID: sde-race
Usage Code: Supplemental Data Description: SDE Race Logic Definition: SDE Race |
Supplemental Data Element |
ID: sde-sex
Usage Code: Supplemental Data Description: SDE Sex Logic Definition: SDE Sex |
Measure Logic | |
Primary Library | CMS104FHIRSTKDCAntithrombotic |
Contents |
Population Criteria
Logic Definitions Terminology Dependencies Data Requirements |
Population Criteria | |
Measure Group (Rate) (ID: Group_1) | |
Initial Population | |
|
|
Denominator | |
|
|
Denominator Exclusion | |
|
|
Numerator | |
|
|
Denominator Exception | |
|
|
Logic Definitions | |
Logic Definition | Library Name: TJCOverall |
|
|
Logic Definition | Library Name: TJCOverall |
|
|
Logic Definition | Library Name: TJCOverall |
|
|
Logic Definition | Library Name: TJCOverall |
|
|
Logic Definition | Library Name: TJCOverall |
|
|
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: CMS104FHIRSTKDCAntithrombotic |
|
|
Logic Definition | Library Name: CMS104FHIRSTKDCAntithrombotic |
|
|
Logic Definition | Library Name: CMS104FHIRSTKDCAntithrombotic |
|
|
Logic Definition | Library Name: CMS104FHIRSTKDCAntithrombotic |
|
|
Logic Definition | Library Name: CMS104FHIRSTKDCAntithrombotic |
|
|
Logic Definition | Library Name: CMS104FHIRSTKDCAntithrombotic |
|
|
Logic Definition | Library Name: CMS104FHIRSTKDCAntithrombotic |
|
|
Logic Definition | Library Name: CMS104FHIRSTKDCAntithrombotic |
|
|
Logic Definition | Library Name: CMS104FHIRSTKDCAntithrombotic |
|
|
Logic Definition | Library Name: CMS104FHIRSTKDCAntithrombotic |
|
|
Logic Definition | Library Name: CMS104FHIRSTKDCAntithrombotic |
|
|
Logic Definition | Library Name: CMS104FHIRSTKDCAntithrombotic |
|
|
Logic Definition | Library Name: CMS104FHIRSTKDCAntithrombotic |
|
|
Logic Definition | Library Name: FHIRHelpers |
|
|
Logic Definition | Library Name: FHIRHelpers |
|
|
Logic Definition | Library Name: FHIRHelpers |
|
|
Logic Definition | Library Name: FHIRHelpers |
|
|
Logic Definition | Library Name: QICoreCommon |
|
|
Logic Definition | Library Name: QICoreCommon |
|
|
Logic Definition | Library Name: QICoreCommon |
|
|
Logic Definition | Library Name: QICoreCommon |
|
|
Logic Definition | Library Name: QICoreCommon |
|
|
Logic Definition | Library Name: QICoreCommon |
|
|
Logic Definition | Library Name: QICoreCommon |
|
|
Logic Definition | Library Name: CQMCommon |
|
|
Logic Definition | Library Name: CQMCommon |
|
|
Logic Definition | Library Name: CQMCommon |
|
|
Logic Definition | Library Name: CQMCommon |
|
|
Logic Definition | Library Name: CQMCommon |
|
|
Terminology | |
Code System |
Description: Code system SNOMEDCT
Resource: SNOMED CT (all versions) Canonical URL: http://snomed.info/sct |
Code System |
Description: Code system Diagnosis Type
Resource: Example Diagnosis Type Codes Canonical URL: http://terminology.hl7.org/CodeSystem/ex-diagnosistype |
Code System |
Description: Code system MedicationRequestCategory
Resource: MedicationRequest Category Codes Canonical URL: http://terminology.hl7.org/CodeSystem/medicationrequest-category |
Code System |
Description: Code system TaskCode
Resource: Task Codes Canonical URL: http://hl7.org/fhir/CodeSystem/task-code |
Value Set |
Description: Value set Nonelective Inpatient Encounter
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.424
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.424 |
Value Set |
Description: Value set Ischemic Stroke
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.247
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.247 |
Value Set |
Description: Value set Antithrombotic Therapy for Ischemic Stroke
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.62
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.62 |
Value Set |
Description: Value set Payer Type
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591 |
Value Set |
Description: Value set Discharge To Acute Care Facility
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.87
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.87 |
Value Set |
Description: Value set Left Against Medical Advice
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.308
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.308 |
Value Set |
Description: Value set Patient Expired
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.309
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.309 |
Value Set |
Description: Value set Discharged to Home for Hospice Care
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.209
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.209 |
Value Set |
Description: Value set Discharged to Health Care Facility for Hospice Care
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.207
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.207 |
Value Set |
Description: Value set Comfort Measures
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.45
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.45 |
Value Set |
Description: Value set Observation Services
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.143
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.143 |
Value Set |
Description: Value set Emergency Department Visit
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.292
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.292 |
Value Set |
Description: Value set Medical Reason For Not Providing Treatment
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.473
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.473 |
Value Set |
Description: Value set Patient Refusal
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.93
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.93 |
Value Set |
Description: Value set Pharmacological Contraindications For Antithrombotic Therapy
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.52
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.52 |
Direct Reference Code |
Display: Male (finding)
Code: 248153007 System: http://snomed.info/sct |
Direct Reference Code |
Display: Female (finding)
Code: 248152002 System: http://snomed.info/sct |
Direct Reference Code |
Display: Principal Diagnosis
Code: principal System: http://terminology.hl7.org/CodeSystem/ex-diagnosistype |
Direct Reference Code |
Display: Community
Code: community System: http://terminology.hl7.org/CodeSystem/medicationrequest-category |
Direct Reference Code |
Display: Discharge
Code: discharge System: http://terminology.hl7.org/CodeSystem/medicationrequest-category |
Direct Reference Code |
Code: fulfill
System: http://hl7.org/fhir/CodeSystem/task-code |
Dependencies | |
Dependency |
Description: Library SDE
Resource: SupplementalDataElementsversion: null5.1.000) Canonical URL: https://madie.cms.gov/Library/SupplementalDataElements|5.1.000 |
Dependency |
Description: Library FHIRHelpers
Resource: FHIRHelpersversion: null4.4.000) Canonical URL: https://madie.cms.gov/Library/FHIRHelpers|4.4.000 |
Dependency |
Description: Library TJC
Resource: TJCOverallversion: null8.24.000) Canonical URL: https://madie.cms.gov/Library/TJCOverall|8.24.000 |
Dependency |
Description: Library CQMCommon
Resource: CQMCommonversion: null4.1.000) Canonical URL: https://madie.cms.gov/Library/CQMCommon|4.1.000 |
Dependency |
Description: Library QICoreCommon
Resource: QICoreCommonversion: null4.0.000) Canonical URL: https://madie.cms.gov/Library/QICoreCommon|4.0.000 |
Data Requirements | |
Data Requirement |
Type: Patient
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient
Must Support Elements: extension, url, birthDate, birthDate.value |
Data Requirement |
Type: Encounter
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter
Must Support Elements: type, status, status.value, period, diagnosis, diagnosis.code Code Filter(s): Path: type ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.143
|
Data Requirement |
Type: Encounter
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter
Must Support Elements: type, status, status.value, period, diagnosis, diagnosis.code Code Filter(s): Path: type ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.292
|
Data Requirement |
Type: Encounter
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter
Must Support Elements: type, period, diagnosis, diagnosis.code, hospitalization, hospitalization.dischargeDisposition Code Filter(s): Path: type ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.424
|
Data Requirement |
Type: Resource
Profile(s): Resource Must Support Elements: id, id.value |
Data Requirement |
Type: Claim
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-claim
Must Support Elements: status, status.value, use, use.value, item |
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis
|
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns
|
Data Requirement |
Type: MedicationRequest
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest
Must Support Elements: medication, status, status.value, intent, intent.value, authoredOn, authoredOn.value Code Filter(s): Path: medication ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.62
|
Data Requirement |
Type: MedicationRequest
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest
Must Support Elements: medication.reference.value, status, status.value |
Data Requirement |
Type: MedicationRequest
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest
Must Support Elements: medication, status, status.value, intent, intent.value, authoredOn, authoredOn.value Code Filter(s): Path: medication ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.52
|
Data Requirement |
Type: Task
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-taskrejected
Must Support Elements: focus, code, statusReason |
Data Requirement |
Type: Coverage
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage
Must Support Elements: type, period Code Filter(s): Path: type ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591
|
Data Requirement |
Type: ServiceRequest
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-servicerequest
Must Support Elements: code, status, status.value, intent, intent.value, doNotPerform, doNotPerform.value Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.45
|
Data Requirement |
Type: Procedure
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure
Must Support Elements: code, status, status.value Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.45
|
Data Requirement |
Type: MedicationRequest
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationnotrequested
Must Support Elements: medication, reasonCode, status, status.value, intent, intent.value Code Filter(s): Path: medication ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.62
|
Data Requirement |
Type: Medication
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medication
Must Support Elements: id.value, code |
Generated using version 0.4.8 of the sample-content-ig Liquid templates |
{ "resourceType": "Measure", "id": "CMS104FHIRSTKDCAntithrombotic", "meta": { "profile": [ "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablemeasure", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-measure-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-measure-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/executable-measure-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cql-measure-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/elm-measure-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm" ] }, "text": { "status": "extensions", "div": "<!-- snip (see above) -->" }, "contained": [ { "resourceType": "Library", "id": "effective-data-requirements", "extension": [ { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://snomed.info/sct", "code": "248153007", "display": "Male (finding)" } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://snomed.info/sct", "code": "248152002", "display": "Female (finding)" } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://terminology.hl7.org/CodeSystem/ex-diagnosistype", "code": "principal", "display": "Principal Diagnosis" } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://terminology.hl7.org/CodeSystem/medicationrequest-category", "code": "community", "display": "Community" } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://terminology.hl7.org/CodeSystem/medicationrequest-category", "code": "discharge", "display": "Discharge" } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://hl7.org/fhir/CodeSystem/task-code", "code": "fulfill" } }, { "extension": [ { "url": "libraryName", "valueString": "SupplementalDataElements" }, { "url": "name", "valueString": "SDE Sex" }, { "url": "statement", "valueString": "define \"SDE Sex\":\n case\n when Patient.sex = '248153007' then \"Male (finding)\"\n when Patient.sex = '248152002' then \"Female (finding)\"\n else null\n end" }, { "url": "displaySequence", "valueInteger": 0 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS104FHIRSTKDCAntithrombotic" }, { "url": "name", "valueString": "SDE Sex" }, { "url": "statement", "valueString": "define \"SDE Sex\":\n SDE.\"SDE Sex\"" }, { "url": "displaySequence", "valueInteger": 1 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "TJCOverall" }, { "url": "name", "valueString": "Non Elective Inpatient Encounter With Age" }, { "url": "statement", "valueString": "define \"Non Elective Inpatient Encounter With Age\":\n [\"Encounter\": \"Nonelective Inpatient Encounter\"] NonElectiveEncounter\n where AgeInYearsAt(date from start of NonElectiveEncounter.period ) >= 18\n and NonElectiveEncounter.period ends during day of \"Measurement Period\"" }, { "url": "displaySequence", "valueInteger": 2 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "TJCOverall" }, { "url": "name", "valueString": "Ischemic Stroke Encounter" }, { "url": "statement", "valueString": "define \"Ischemic Stroke Encounter\":\n \"Non Elective Inpatient Encounter With Age\" NonElectiveEncounterWithAge\n where NonElectiveEncounterWithAge.hasPrincipalDiagnosisOf(\"Ischemic Stroke\" )" }, { "url": "displaySequence", "valueInteger": 3 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS104FHIRSTKDCAntithrombotic" }, { "url": "name", "valueString": "Numerator" }, { "url": "statement", "valueString": "define \"Numerator\":\n TJC.\"Ischemic Stroke Encounter\" IschemicStrokeEncounter\n with [\"MedicationRequest\": medication in \"Antithrombotic Therapy for Ischemic Stroke\"] DischargeAntithrombotic\n such that DischargeAntithrombotic.status in { 'active', 'completed' }\n and DischargeAntithrombotic.intent in { 'order', 'original-order', 'reflex-order', 'filler-order', 'instance-order' }\n and ( DischargeAntithrombotic.isCommunity ( )\n or DischargeAntithrombotic.isDischarge ( )\n )\n and DischargeAntithrombotic.authoredOn during IschemicStrokeEncounter.period\n and not exists ( [\"TaskRejected\"] TaskReject\n where TaskReject.focus.references ( DischargeAntithrombotic )\n and TaskReject.code ~ \"fulfill\"\n )" }, { "url": "displaySequence", "valueInteger": 4 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS104FHIRSTKDCAntithrombotic" }, { "url": "name", "valueString": "Initial Population" }, { "url": "statement", "valueString": "define \"Initial Population\":\n TJC.\"Ischemic Stroke Encounter\"" }, { "url": "displaySequence", "valueInteger": 5 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS104FHIRSTKDCAntithrombotic" }, { "url": "name", "valueString": "Denominator" }, { "url": "statement", "valueString": "define \"Denominator\":\n \"Initial Population\"" }, { "url": "displaySequence", "valueInteger": 6 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "SupplementalDataElements" }, { "url": "name", "valueString": "SDE Payer" }, { "url": "statement", "valueString": "define \"SDE Payer\":\n [Coverage: type in \"Payer Type\"] Payer\n return {\n code: Payer.type,\n period: Payer.period\n }" }, { "url": "displaySequence", "valueInteger": 7 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS104FHIRSTKDCAntithrombotic" }, { "url": "name", "valueString": "SDE Payer" }, { "url": "statement", "valueString": "define \"SDE Payer\":\n SDE.\"SDE Payer\"" }, { "url": "displaySequence", "valueInteger": 8 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "SupplementalDataElements" }, { "url": "name", "valueString": "SDE Ethnicity" }, { "url": "statement", "valueString": "define \"SDE Ethnicity\":\n Patient.ethnicity E\n return Tuple {\n codes: { E.ombCategory } union E.detailed,\n display: E.text\n }" }, { "url": "displaySequence", "valueInteger": 9 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS104FHIRSTKDCAntithrombotic" }, { "url": "name", "valueString": "SDE Ethnicity" }, { "url": "statement", "valueString": "define \"SDE Ethnicity\":\n SDE.\"SDE Ethnicity\"" }, { "url": "displaySequence", "valueInteger": 10 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "TJCOverall" }, { "url": "name", "valueString": "Ischemic Stroke Encounters With Discharge Disposition" }, { "url": "statement", "valueString": "define \"Ischemic Stroke Encounters With Discharge Disposition\":\n \"Ischemic Stroke Encounter\" IschemicStrokeEncounter\n let DischDisp: IschemicStrokeEncounter.hospitalization.dischargeDisposition\n \twhere DischDisp in \"Discharge To Acute Care Facility\"\n\t\tor DischDisp in \"Left Against Medical Advice\"\n\t\tor DischDisp in \"Patient Expired\"\n\t\tor DischDisp in \"Discharged to Home for Hospice Care\"\n\t\tor DischDisp in \"Discharged to Health Care Facility for Hospice Care\"" }, { "url": "displaySequence", "valueInteger": 11 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "TJCOverall" }, { "url": "name", "valueString": "Intervention Comfort Measures" }, { "url": "statement", "valueString": "define \"Intervention Comfort Measures\":\n ( [\"ServiceRequest\": code in \"Comfort Measures\"] SR\n where SR.status in { 'active', 'completed', 'on-hold' }\n and SR.intent in { 'order', 'original-order', 'reflex-order', 'filler-order', 'instance-order' }\n and SR.doNotPerform is not true\n ) \n union ( [\"Procedure\": \"Comfort Measures\"] InterventionPerformed\n where InterventionPerformed.status in { 'completed', 'in-progress' }\n )" }, { "url": "displaySequence", "valueInteger": 12 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "TJCOverall" }, { "url": "name", "valueString": "Encounter With Comfort Measures During Hospitalization" }, { "url": "statement", "valueString": "define \"Encounter With Comfort Measures During Hospitalization\":\n \"Ischemic Stroke Encounter\" IschemicStrokeEncounter\n with \"Intervention Comfort Measures\" ComfortMeasure\n such that Coalesce(start of ComfortMeasure.performed.toInterval(), ComfortMeasure.authoredOn) during IschemicStrokeEncounter.hospitalizationWithObservation()" }, { "url": "displaySequence", "valueInteger": 13 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS104FHIRSTKDCAntithrombotic" }, { "url": "name", "valueString": "Denominator Exclusions" }, { "url": "statement", "valueString": "define \"Denominator Exclusions\":\n TJC.\"Ischemic Stroke Encounters With Discharge Disposition\"\n union TJC.\"Encounter With Comfort Measures During Hospitalization\"" }, { "url": "displaySequence", "valueInteger": 14 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "SupplementalDataElements" }, { "url": "name", "valueString": "SDE Race" }, { "url": "statement", "valueString": "define \"SDE Race\":\n Patient.race R\n return Tuple {\n codes: R.ombCategory union R.detailed,\n display: R.text\n }" }, { "url": "displaySequence", "valueInteger": 15 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS104FHIRSTKDCAntithrombotic" }, { "url": "name", "valueString": "SDE Race" }, { "url": "statement", "valueString": "define \"SDE Race\":\n SDE.\"SDE Race\"" }, { "url": "displaySequence", "valueInteger": 16 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS104FHIRSTKDCAntithrombotic" }, { "url": "name", "valueString": "Reason For Not Giving Antithrombotic At Discharge" }, { "url": "statement", "valueString": "define \"Reason For Not Giving Antithrombotic At Discharge\":\n ( [\"MedicationNotRequested\": \"Antithrombotic Therapy for Ischemic Stroke\"] NoAntithromboticDischarge\n where ( NoAntithromboticDischarge.reasonCode in \"Medical Reason For Not Providing Treatment\"\n or NoAntithromboticDischarge.reasonCode in \"Patient Refusal\"\n )\n and ( NoAntithromboticDischarge.isCommunity ( )\n or NoAntithromboticDischarge.isDischarge ( )\n )\n and NoAntithromboticDischarge.status in { 'active', 'completed' }\n and NoAntithromboticDischarge.intent in { 'order', 'original-order', 'reflex-order', 'filler-order', 'instance-order' }\n )\n union ( [\"MedicationRequest\": \"Antithrombotic Therapy for Ischemic Stroke\"] MedReqAntithrombotic\n with [\"TaskRejected\"] TaskReject\n such that TaskReject.focus.references ( MedReqAntithrombotic )\n and ( TaskReject.statusReason in \"Medical Reason For Not Providing Treatment\"\n or TaskReject.statusReason in \"Patient Refusal\"\n )\n and MedReqAntithrombotic.status = 'active'\n and TaskReject.code ~ \"fulfill\"\n )" }, { "url": "displaySequence", "valueInteger": 17 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS104FHIRSTKDCAntithrombotic" }, { "url": "name", "valueString": "Encounter With Documented Reason For No Antithrombotic At Discharge" }, { "url": "statement", "valueString": "define \"Encounter With Documented Reason For No Antithrombotic At Discharge\":\n TJC.\"Ischemic Stroke Encounter\" IschemicStrokeEncounter\n with \"Reason For Not Giving Antithrombotic At Discharge\" NoDischargeAntithrombotic\n such that NoDischargeAntithrombotic.authoredOn during IschemicStrokeEncounter.period" }, { "url": "displaySequence", "valueInteger": 18 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS104FHIRSTKDCAntithrombotic" }, { "url": "name", "valueString": "Pharmacological Contraindications For Antithrombotic Therapy At Discharge" }, { "url": "statement", "valueString": "define \"Pharmacological Contraindications For Antithrombotic Therapy At Discharge\":\n [\"MedicationRequest\": medication in \"Pharmacological Contraindications For Antithrombotic Therapy\"] PharmacologicalContraindications\n where ( PharmacologicalContraindications.isCommunity ( )\n or PharmacologicalContraindications.isDischarge ( )\n )\n and PharmacologicalContraindications.status in { 'active', 'completed' }\n and PharmacologicalContraindications.intent in { 'order', 'original-order', 'reflex-order', 'filler-order', 'instance-order' }" }, { "url": "displaySequence", "valueInteger": 19 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS104FHIRSTKDCAntithrombotic" }, { "url": "name", "valueString": "Encounter With Pharmacological Contraindications For Antithrombotic Therapy At Discharge" }, { "url": "statement", "valueString": "define \"Encounter With Pharmacological Contraindications For Antithrombotic Therapy At Discharge\":\n TJC.\"Ischemic Stroke Encounter\" IschemicStrokeEncounter\n with \"Pharmacological Contraindications For Antithrombotic Therapy At Discharge\" DischargePharmacological\n such that DischargePharmacological.authoredOn during IschemicStrokeEncounter.period" }, { "url": "displaySequence", "valueInteger": 20 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS104FHIRSTKDCAntithrombotic" }, { "url": "name", "valueString": "Denominator Exceptions" }, { "url": "statement", "valueString": "define \"Denominator Exceptions\":\n \"Encounter With Documented Reason For No Antithrombotic At Discharge\"\n union \"Encounter With Pharmacological Contraindications For Antithrombotic Therapy At Discharge\"" }, { "url": "displaySequence", "valueInteger": 21 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "FHIRHelpers" }, { "url": "name", "valueString": "ToString" }, { "url": "statement", "valueString": "define function ToString(value uri): value.value" }, { "url": "displaySequence", "valueInteger": 22 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "FHIRHelpers" }, { "url": "name", "valueString": "ToInterval" }, { "url": "statement", "valueString": "/*\n@description: Converts the given [Period](https://hl7.org/fhir/datatypes.html#Period)\nvalue to a CQL DateTime Interval\n@comment: If the start value of the given period is unspecified, the starting\nboundary of the resulting interval will be open (meaning the start of the interval\nis unknown, as opposed to interpreted as the beginning of time).\n*/\ndefine function ToInterval(period FHIR.Period):\n if period is null then\n null\n else\n if period.\"start\" is null then\n Interval(period.\"start\".value, period.\"end\".value]\n else\n Interval[period.\"start\".value, period.\"end\".value]" }, { "url": "displaySequence", "valueInteger": 23 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CQMCommon" }, { "url": "name", "valueString": "hasPrincipalDiagnosisOf" }, { "url": "statement", "valueString": "/*\n @description: Returns the condition that is specified as the principal diagnosis for the encounter and has a code in the given valueSet.\n @comment: See the QICore 6 Authoring Patterns discussion on [Principal Diagnosis and Present on Admission](https://github.com/cqframework/CQL-Formatting-and-Usage-Wiki/wiki/Authoring-Patterns-QICore-v6.0.0#conditions-present-on-admission-and-principal-diagnoses) for more information\n */\n define fluent function hasPrincipalDiagnosisOf(encounter Encounter, valueSet ValueSet):\n (encounter.principalDiagnosis()) PD\n return PD.diagnosis in valueSet\n or PD.diagnosis.getCondition().code in valueSet" }, { "url": "displaySequence", "valueInteger": 24 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CQMCommon" }, { "url": "name", "valueString": "principalDiagnosis" }, { "url": "statement", "valueString": "/*\n@description: Returns the claim diagnosis element that is specified as the principal diagnosis for the encounter\n @comment: See the QICore 6 Authoring Patterns discussion on [Principal Diagnosis and Present on Admission](https://github.com/cqframework/CQL-Formatting-and-Usage-Wiki/wiki/Authoring-Patterns-QICore-v6.0.0#conditions-present-on-admission-and-principal-diagnoses) for more information\n*/\ndefine fluent function principalDiagnosis(encounter Encounter):\nsingleton from (\n (encounter.claimDiagnosis()) CD\n where CD.type.includesCode(\"Principal Diagnosis\")\n )" }, { "url": "displaySequence", "valueInteger": 25 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CQMCommon" }, { "url": "name", "valueString": "claimDiagnosis" }, { "url": "statement", "valueString": "/*\n@description: Returns the claim diagnosis elements for the given encounter\n@comment: See the QICore 6 Authoring Patterns discussion on [Principal Diagnosis and Present on Admission](https://github.com/cqframework/CQL-Formatting-and-Usage-Wiki/wiki/Authoring-Patterns-QICore-v6.0.0#conditions-present-on-admission-and-principal-diagnoses) for more information\n*/\ndefine fluent function claimDiagnosis(encounter Encounter):\n encounter E\n let \n claim: ([Claim] C where C.status = 'active' and C.use = 'claim' and exists (C.item I where I.encounter.references(E))),\n claimItem: (claim.item I where I.encounter.references(E))\n return claim.diagnosis D where D.sequence in claimItem.diagnosisSequence" }, { "url": "displaySequence", "valueInteger": 26 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "QICoreCommon" }, { "url": "name", "valueString": "references" }, { "url": "statement", "valueString": "/*\n@description: Returns true if any of the given references are to the given resource\n@comment: Returns true if the `id` element of the given resource exactly equals the tail of any of the given references.\nNOTE: This function assumes resources from the same source server.\n*/\ndefine fluent function references(references List<Reference>, resource Resource):\n exists (references R where R.references(resource))" }, { "url": "displaySequence", "valueInteger": 27 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "QICoreCommon" }, { "url": "name", "valueString": "references" }, { "url": "statement", "valueString": "/*\n@description: Returns true if the given reference is to the given resource\n@comment: Returns true if the `id` element of the given resource exactly equals the tail of the given reference.\nNOTE: This function assumes resources from the same source server.\n*/\ndefine fluent function references(reference Reference, resource Resource):\n resource.id = Last(Split(reference.reference, '/'))" }, { "url": "displaySequence", "valueInteger": 28 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "QICoreCommon" }, { "url": "name", "valueString": "includesCode" }, { "url": "statement", "valueString": "/*\n@description: Returns true if the given code is in the given codeList\n@comment: Returns true if the `code` is equivalent to any of the codes in the given `codeList`, false otherwise.\n*/\ndefine fluent function includesCode(codeList List<Concept>, code Code):\n exists (codeList C where C ~ code)" }, { "url": "displaySequence", "valueInteger": 29 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "FHIRHelpers" }, { "url": "name", "valueString": "ToConcept" }, { "url": "statement", "valueString": "/*\n@description: Converts the given FHIR [CodeableConcept](https://hl7.org/fhir/datatypes.html#CodeableConcept) value to a CQL Concept.\n*/\ndefine function ToConcept(concept FHIR.CodeableConcept):\n if concept is null then\n null\n else\n System.Concept {\n codes: concept.coding C return ToCode(C),\n display: concept.text.value\n }" }, { "url": "displaySequence", "valueInteger": 30 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "FHIRHelpers" }, { "url": "name", "valueString": "ToCode" }, { "url": "statement", "valueString": "/*\n@description: Converts the given FHIR [Coding](https://hl7.org/fhir/datatypes.html#Coding) value to a CQL Code.\n*/\ndefine function ToCode(coding FHIR.Coding):\n if coding is null then\n null\n else\n System.Code {\n code: coding.code.value,\n system: coding.system.value,\n version: coding.version.value,\n display: coding.display.value\n }" }, { "url": "displaySequence", "valueInteger": 31 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CQMCommon" }, { "url": "name", "valueString": "getCondition" }, { "url": "statement", "valueString": "/*\n@description: Returns the Condition resource for the given reference\n*/\ndefine fluent function getCondition(reference Reference):\n singleton from (([ConditionEncounterDiagnosis] union [ConditionProblemsHealthConcerns]) C where reference.references(C.id))" }, { "url": "displaySequence", "valueInteger": 32 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "QICoreCommon" }, { "url": "name", "valueString": "references" }, { "url": "statement", "valueString": "/*\n@description: Returns true if the given reference is to the given resourceId\n@comment: Returns true if the `resourceId` parameter exactly equals the tail of the given reference.\nNOTE: This function assumes resources from the same source server.\n*/\ndefine fluent function references(reference Reference, resourceId String):\n resourceId = Last(Split(reference.reference, '/'))" }, { "url": "displaySequence", "valueInteger": 33 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "QICoreCommon" }, { "url": "name", "valueString": "isCommunity" }, { "url": "statement", "valueString": "/*\n@description: Returns true if the given MedicationRequest has a category of Community\n*/\ndefine fluent function isCommunity(medicationRequest Choice<MedicationRequest, MedicationNotRequested>):\n exists (medicationRequest.category C\n where C ~ Community\n )" }, { "url": "displaySequence", "valueInteger": 34 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "QICoreCommon" }, { "url": "name", "valueString": "isDischarge" }, { "url": "statement", "valueString": "/*\n@description: Returns true if the given MedicationRequest has a category of Discharge\n*/\ndefine fluent function isDischarge(medicationRequest Choice<MedicationRequest, MedicationNotRequested>):\n exists (medicationRequest.category C\n where C ~ Discharge\n )" }, { "url": "displaySequence", "valueInteger": 35 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "QICoreCommon" }, { "url": "name", "valueString": "toInterval" }, { "url": "statement", "valueString": "/*\n@description: Normalizes a value that is a choice of timing-valued types to an equivalent interval\n@comment: Normalizes a choice type of DateTime, Quanitty, Interval<DateTime>, or Interval<Quantity> types\nto an equivalent interval. This selection of choice types is a superset of the majority of choice types that are used as possible\nrepresentations for timing-valued elements in QICore, allowing this function to be used across any resource.\nThe input can be provided as a DateTime, Quantity, Interval<DateTime> or Interval<Quantity>.\nThe intent of this function is to provide a clear and concise mechanism to treat single\nelements that have multiple possible representations as intervals so that logic doesn't have to account\nfor the variability. More complex calculations (such as medication request period or dispense period\ncalculation) need specific guidance and consideration. That guidance may make use of this function, but\nthe focus of this function is on single element calculations where the semantics are unambiguous.\nIf the input is a DateTime, the result a DateTime Interval beginning and ending on that DateTime.\nIf the input is a Quantity, the quantity is expected to be a calendar-duration interpreted as an Age,\nand the result is a DateTime Interval beginning on the Date the patient turned that age and ending immediately before one year later.\nIf the input is a DateTime Interval, the result is the input.\nIf the input is a Quantity Interval, the quantities are expected to be calendar-durations interpreted as an Age, and the result\nis a DateTime Interval beginning on the date the patient turned the age given as the start of the quantity interval, and ending\nimmediately before one year later than the date the patient turned the age given as the end of the quantity interval.\nIf the input is a Timing, an error will be thrown indicating that Timing calculations are not implemented. Any other input will reslt in a null DateTime Interval\n*/\ndefine fluent function toInterval(choice Choice<DateTime, Quantity, Interval<DateTime>, Interval<Quantity>, Timing>):\n case\n\t when choice is DateTime then\n \tInterval[choice as DateTime, choice as DateTime]\n\t\twhen choice is Interval<DateTime> then\n \t\tchoice as Interval<DateTime>\n\t\twhen choice is Quantity then\n\t\t Interval[Patient.birthDate + (choice as Quantity),\n\t\t\t Patient.birthDate + (choice as Quantity) + 1 year)\n\t\twhen choice is Interval<Quantity> then\n\t\t Interval[Patient.birthDate + (choice.low as Quantity),\n\t\t\t Patient.birthDate + (choice.high as Quantity) + 1 year)\n\t\twhen choice is Timing then\n Message(null, true, 'NOT_IMPLEMENTED', 'Error', 'Calculation of an interval from a Timing value is not supported') as Interval<DateTime>\n\t\telse\n\t\t\tnull as Interval<DateTime>\n\tend" }, { "url": "displaySequence", "valueInteger": 36 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CQMCommon" }, { "url": "name", "valueString": "hospitalizationWithObservation" }, { "url": "statement", "valueString": "/*\n@description: Hospitalization with Observation returns the total interval from the start of any immediately prior emergency department visit through the observation visit to the discharge of the given encounter\n*/\ndefine fluent function hospitalizationWithObservation(TheEncounter Encounter ):\n TheEncounter Visit\n \t\tlet ObsVisit: Last([Encounter: \"Observation Services\"] LastObs\n \t\t\t\twhere LastObs.status = 'finished'\n and LastObs.period ends 1 hour or less on or before start of Visit.period\n \t\t\t\tsort by end of period\n \t\t\t),\n \t\t\tVisitStart: Coalesce(start of ObsVisit.period, start of Visit.period),\n \t\t\tEDVisit: Last([Encounter: \"Emergency Department Visit\"] LastED\n \t\t\t\twhere LastED.status = 'finished'\n and LastED.period ends 1 hour or less on or before VisitStart\n \t\t\t\tsort by end of period\n \t\t\t)\n \t\treturn Interval[Coalesce(start of EDVisit.period, VisitStart), end of Visit.period]" }, { "url": "displaySequence", "valueInteger": 37 } ], "url": "http://hl7.org/fhir/StructureDefinition/cqf-logicDefinition" } ], "name": "EffectiveDataRequirements", "status": "active", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/library-type", "code": "module-definition" } ] }, "relatedArtifact": [ { "type": "depends-on", "display": "Library SDE", "resource": "https://madie.cms.gov/Library/SupplementalDataElements|5.1.000" }, { "type": "depends-on", "display": "Library FHIRHelpers", "resource": "https://madie.cms.gov/Library/FHIRHelpers|4.4.000" }, { "type": "depends-on", "display": "Library TJC", "resource": "https://madie.cms.gov/Library/TJCOverall|8.24.000" }, { "type": "depends-on", "display": "Library CQMCommon", "resource": "https://madie.cms.gov/Library/CQMCommon|4.1.000" }, { "type": "depends-on", "display": "Library QICoreCommon", "resource": "https://madie.cms.gov/Library/QICoreCommon|4.0.000" }, { "type": "depends-on", "display": "Code system SNOMEDCT", "resource": "http://snomed.info/sct" }, { "type": "depends-on", "display": "Code system Diagnosis Type", "resource": "http://terminology.hl7.org/CodeSystem/ex-diagnosistype" }, { "type": "depends-on", "display": "Code system MedicationRequestCategory", "resource": "http://terminology.hl7.org/CodeSystem/medicationrequest-category" }, { "type": "depends-on", "display": "Code system TaskCode", "resource": "http://hl7.org/fhir/CodeSystem/task-code" }, { "type": "depends-on", "display": "Value set Nonelective Inpatient Encounter", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.424" }, { "type": "depends-on", "display": "Value set Ischemic Stroke", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.247" }, { "type": "depends-on", "display": "Value set Antithrombotic Therapy for Ischemic Stroke", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.62" }, { "type": "depends-on", "display": "Value set Payer Type", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591" }, { "type": "depends-on", "display": "Value set Discharge To Acute Care Facility", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.87" }, { "type": "depends-on", "display": "Value set Left Against Medical Advice", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.308" }, { "type": "depends-on", "display": "Value set Patient Expired", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.309" }, { "type": "depends-on", "display": "Value set Discharged to Home for Hospice Care", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.209" }, { "type": "depends-on", "display": "Value set Discharged to Health Care Facility for Hospice Care", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.207" }, { "type": "depends-on", "display": "Value set Comfort Measures", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.45" }, { "type": "depends-on", "display": "Value set Observation Services", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.143" }, { "type": "depends-on", "display": "Value set Emergency Department Visit", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.292" }, { "type": "depends-on", "display": "Value set Medical Reason For Not Providing Treatment", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.473" }, { "type": "depends-on", "display": "Value set Patient Refusal", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.93" }, { "type": "depends-on", "display": "Value set Pharmacological Contraindications For Antithrombotic Therapy", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.52" } ], "parameter": [ { "name": "Measurement Period", "use": "in", "min": 0, "max": "1", "type": "Period" }, { "name": "Numerator", "use": "out", "min": 0, "max": "*", "type": "Resource" }, { "name": "Denominator", "use": "out", "min": 0, "max": "*", "type": "Resource" }, { "name": "Initial Population", "use": "out", "min": 0, "max": "*", "type": "Resource" }, { "name": "Denominator Exclusions", "use": "out", "min": 0, "max": "*", "type": "Resource" }, { "name": "Denominator Exceptions", "use": "out", "min": 0, "max": "*", "type": "Resource" }, { "name": "SDE Sex", "use": "out", "min": 0, "max": "1", "type": "Coding" }, { "name": "SDE Payer", "use": "out", "min": 0, "max": "*", "type": "Resource" }, { "name": "SDE Ethnicity", "use": "out", "min": 0, "max": "1", "type": "Resource" }, { "name": "SDE Race", "use": "out", "min": 0, "max": "1", "type": "Resource" } ], "dataRequirement": [ { "type": "Patient", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient" ], "mustSupport": [ "extension", "url", "birthDate", "birthDate.value" ] }, { "type": "Encounter", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter" ], "mustSupport": [ "type", "status", "status.value", "period", "diagnosis", "diagnosis.code" ], "codeFilter": [ { "path": "type", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.143" } ] }, { "type": "Encounter", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter" ], "mustSupport": [ "type", "status", "status.value", "period", "diagnosis", "diagnosis.code" ], "codeFilter": [ { "path": "type", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.292" } ] }, { "type": "Encounter", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter" ], "mustSupport": [ "type", "period", "diagnosis", "diagnosis.code", "hospitalization", "hospitalization.dischargeDisposition" ], "codeFilter": [ { "path": "type", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.424" } ] }, { "type": "Resource", "profile": [ "http://hl7.org/fhir/StructureDefinition/Resource" ], "mustSupport": [ "id", "id.value" ] }, { "type": "Claim", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-claim" ], "mustSupport": [ "status", "status.value", "use", "use.value", "item" ] }, { "type": "Condition", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis" ] }, { "type": "Condition", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns" ] }, { "type": "MedicationRequest", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest" ], "mustSupport": [ "medication", "status", "status.value", "intent", "intent.value", "authoredOn", "authoredOn.value" ], "codeFilter": [ { "path": "medication", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.62" } ] }, { "type": "MedicationRequest", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest" ], "mustSupport": [ "medication.reference.value", "status", "status.value" ] }, { "type": "MedicationRequest", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest" ], "mustSupport": [ "medication", "status", "status.value", "intent", "intent.value", "authoredOn", "authoredOn.value" ], "codeFilter": [ { "path": "medication", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.52" } ] }, { "type": "Task", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-taskrejected" ], "mustSupport": [ "focus", "code", "statusReason" ] }, { "type": "Coverage", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage" ], "mustSupport": [ "type", "period" ], "codeFilter": [ { "path": "type", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591" } ] }, { "type": "ServiceRequest", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-servicerequest" ], "mustSupport": [ "code", "status", "status.value", "intent", "intent.value", "doNotPerform", "doNotPerform.value" ], "codeFilter": [ { "path": "code", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.45" } ] }, { "type": "Procedure", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure" ], "mustSupport": [ "code", "status", "status.value" ], "codeFilter": [ { "path": "code", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.45" } ] }, { "type": "MedicationRequest", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationnotrequested" ], "mustSupport": [ "medication", "reasonCode", "status", "status.value", "intent", "intent.value" ], "codeFilter": [ { "path": "medication", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.62" } ] }, { "type": "MedicationRequest", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationnotrequested" ], "mustSupport": [ "medication", "reasonCode", "status", "status.value", "intent", "intent.value" ], "codeFilter": [ { "path": "medication", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.62" } ] }, { "type": "Medication", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medication" ], "mustSupport": [ "id.value", "code" ] } ] } ], "extension": [ { "id": "supplementalDataGuidance", "extension": [ { "url": "guidance", "valueString": "For every patient evaluated by this measure also identify payer, race, ethnicity and sex; SDE Ethnicity-Patient's Ethnicity:\nHispanic or Latino\nNot Hispanic or Latino\n \n SDE Payer-Patient's Payer:\nCategories of types of health care payer entities as defined by the US Public Health Data Consortium SOP code system\n \n SDE Race-Patient's Race:\nNative Hawaiian or Other Pacific Islander\nAsian\nAmerican Indian or Alaska Native\nOther Race\nWhite\nBlack or African American\n \n SDE Sex-Patient's Sex:\nGender identity restricted to only Male and Female used in administrative situations requiring a restriction to these two categories.\n \n " }, { "url": "usage", "valueCodeableConcept": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-data-usage", "code": "supplemental-data", "display": "Supplemental Data" } ], "text": "Supplemental Data Guidance" } } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-supplementalDataGuidance" }, { "url": "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-effectiveDataRequirements", "valueReference": { "reference": "#effective-data-requirements" } } ], "url": "https://madie.cms.gov/Measure/CMS104FHIRSTKDCAntithrombotic", "identifier": [ { "use": "usual", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/artifact-identifier-type", "code": "short-name", "display": "Short Name" } ] }, "system": "https://madie.cms.gov/measure/shortName", "value": "CMS104FHIR" }, { "use": "official", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/artifact-identifier-type", "code": "version-independent", "display": "Version Independent" } ] }, "system": "urn:ietf:rfc:3986", "value": "urn:uuid:4f57e4a2-097b-45f8-9c85-91b35ea92dc1" }, { "use": "official", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/artifact-identifier-type", "code": "version-specific", "display": "Version Specific" } ] }, "system": "urn:ietf:rfc:3986", "value": "urn:uuid:3e24cf04-e7a8-4f7d-b9bc-3c3e3b1b39b6" }, { "use": "official", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/artifact-identifier-type", "code": "publisher", "display": "Publisher" } ] }, "system": "https://madie.cms.gov/measure/cmsId", "value": "104FHIR", "assigner": { "display": "CMS" } } ], "version": "0.9.003", "name": "CMS104FHIRSTKDCAntithrombotic", "title": "Discharged on Antithrombotic TherapyFHIR", "status": "active", "experimental": false, "date": "2025-06-20T21:30:13+00:00", "publisher": "The Joint Commission", "contact": [ { "telecom": [ { "system": "url", "value": "https://www.jointcommission.org/" } ] } ], "description": "Ischemic stroke patients prescribed or continuing to take antithrombotic therapy at hospital discharge", "usage": "The \"Nonelective Inpatient Encounter\" value set intends to capture all non-scheduled hospitalizations. This value set is a subset of the \"Inpatient encounter\" value set, excluding concepts that specifically refer to elective hospital admissions. Non-elective admissions include emergency, urgent and unplanned admissions.\n\nThe \"Medication, Discharge\" datatype refers to the discharge medication list and is intended to express medications ordered for post-discharge use.\n\nThe denominator population includes patients with inpatient hospitalizations and patients from Acute Hospital Care at Home programs, who are treated and billed as inpatients but receive care in their home.\n\nThis dQM is an episode-based measure. An episode is defined as each inpatient hospitalization or encounter that ends during the measurement period. This FHIR-based measure has been derived from the QDM-based measure: CMS104v14. Please refer to the HL7 QI-Core Implementation Guide (https://hl7.org/fhir/us/qicore/STU6/) for more information on QI-Core and mapping recommendations from QDM to QI-Core STU 6. (https://hl7.org/fhir/us/qicore/STU6/qdm-to-qicore.html).", "copyright": "Measure specifications are in the Public Domain\n\nLOINC(R) copyright 2004-2024 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2024 International Health Terminology Standards Development Organisation. ICD-10 copyright 2024 World Health Organization. All Rights Reserved.", "effectivePeriod": { "start": "2026-01-01", "end": "2026-12-31" }, "author": [ { "name": "The Joint Commission", "telecom": [ { "system": "url", "value": "https://www.jointcommission.org/" } ] } ], "relatedArtifact": [ { "type": "citation", "citation": "CITATION - Adams, H., Adams, R., del Zoppo, G., et al. (2005, April). Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update—A scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke, 36(4): 916-923. \n" }, { "type": "citation", "citation": "CITATION - Adams, H. P., Jr., del Zoppo, G., Alberts, M. J., et al. (2007, May). Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke, 38(5), 1655-1711. \n" }, { "type": "citation", "citation": "CITATION - Albers, G. W, Amarenco, P., Easton, J. D., et al. (2001). Antithrombotic and thrombolytic therapy for ischemic stroke. Chest, 119, 300-320. \n" }, { "type": "citation", "citation": "CITATION - Albers, G. W., Amarenco, P., Easton, J. D., et al. (2004, September). Antithrombotic and thrombolytic therapy for ischemic stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126(3), 483S-512S. \n" }, { "type": "citation", "citation": "CITATION - Antiplatelet Trialists’ Collaboration. (1994, January 8). Collaborative overview of randomised trials of antiplatelet therapy—I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ, 308(6921), 81-106. \n" }, { "type": "citation", "citation": "CITATION - Antithrombotic Trialists’ Collaboration. (2002, January 12). Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ, 324(7329), 71-86. \n" }, { "type": "citation", "citation": "CITATION - Bhatt, D. L., Fox, K. A., Hacke, W., et al. (2006, April 20). Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. New England Journal of Medicine, 354(16), 1706-1717. \n" }, { "type": "citation", "citation": "CITATION - Brott, T. G., Clark, W. M., Fagan, S. C., et al. (2000). Stroke: The first hours. Guidelines for acute treatment. Washington, DC: National Stroke Association. \n" }, { "type": "citation", "citation": "CITATION - Canadian Cooperative Study Group. (1978, July 13). A randomized trial of aspirin and sulfinpyrazone in threatened stroke. New England Journal of Medicine, 299(2), 53-59.\n" }, { "type": "citation", "citation": "CITATION - CAPRIE Steering Committee. (1996, November 16). A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 348(9038), 1329-1339.\n" }, { "type": "citation", "citation": "CITATION - Centers for Disease Control and Prevention. (2009, May 1). Prevalence and most common causes of disability among adults—United States, 2005. Morbidity and Mortality Weekly Report, 58(16), 421-426. \n" }, { "type": "citation", "citation": "CITATION - Chen, Z. M., Sandercock, P., Pan, H. C., et al. (2000, June). Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40,000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke, 31(6), 1240-1249. \n" }, { "type": "citation", "citation": "CITATION - Coull, B. M., Williams, L. S., Goldstein, L. B., et al. (2002, July). Anticoagulants and antiplatelet agents in acute ischemic stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association). Stroke, 33(7), 1934-1942. \n" }, { "type": "citation", "citation": "CITATION - Diener, H. C., Bogousslavsky, J., Brass, L. M., et al. (2004, July). Aspirin and lopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial. Lancet, 364(9431), 331-337. \n" }, { "type": "citation", "citation": "CITATION - Dutch Tia Trial Study Group. (1991, October 31). A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. New England Journal of Medicine, 325(18), 1261-1266. \n" }, { "type": "citation", "citation": "CITATION - Eccles, M., Freemantle, N., & Mason, J. (1998, April 25). North of England Evidence-Based Guideline Development Project: Guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. BMJ, 316(7140), 1303-1309. \n" }, { "type": "citation", "citation": "CITATION - ESPRIT Study Group, Halkes, P. H., van Gijn, J., et al. (2006, May 20). Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomised controlled trial. Lancet, 367(9523), 1665-1673. \n" }, { "type": "citation", "citation": "CITATION - ESPS Group. (1987, December 12). The European Stroke Prevention Study (ESPS): Principal end-points. Lancet, 2(8572), 1351-1354. \n" }, { "type": "citation", "citation": "CITATION - Farrell, B., Godwin, J., Richards, S., et al. (1991, December). The United Kingdom Transient Ischaemic Attack (Uk-Tia) Aspirin Trial: Final results. Journal of Neurology, Neurosurgery, and Psychiatry, 54(12), 1044-1054. \n" }, { "type": "citation", "citation": "CITATION - Gaspoz, J. M., Coxson, P. G., Goldman, P. A., et al. (2002, June 6). Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. New England Journal of Medicine, 346(23), 1800-1806. \n" }, { "type": "citation", "citation": "CITATION - Gent, M., Blakely, J. A., Easton, J. D., et al. (1989, June 3). The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1(8649), 1215-1220. \n" }, { "type": "citation", "citation": "CITATION - Gorelick, P. B., Richardson, D., Kelly, M., et al. (2003, June 11). Aspirin and ticlopidine for prevention of recurrent stroke in black patients: A randomized trial. JAMA, 289(22), 2947-2957. \n" }, { "type": "citation", "citation": "CITATION - Guyatt, G. H., Akl, E. A., Crowther, M., et al. (2012, February). Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 141(2 Suppl.), 7S-47S. \n" }, { "type": "citation", "citation": "CITATION - Guyatt, G., Schunemann, H., Cook, D., et al. (2001, January). Grades of recommendation for antithrombotic agents. Chest, 119(1 Suppl.), 3S-7S. \n" }, { "type": "citation", "citation": "CITATION - Hass, W. K., Easton, J. D., Adams, H. P., Jr., et al. (1989, August 24). Randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. New England Journal of Medicine, 321(8), 501-507. \n" }, { "type": "citation", "citation": "CITATION - International Stroke Trial Collaborative Group. (1997, May 31). The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet, 349(9065), 1569-1581. \n" }, { "type": "citation", "citation": "CITATION - Jauch, E. C., Saver, J. L., Adams, H. P., Jr., et al. (2013). Guidelines for the early management of patients with acute ischemic stroke: A guideline for health care professionals from the American Heart Association/American Stroke Association. Stroke, 44(3), 870-947. \n" }, { "type": "citation", "citation": "CITATION - Johnson, E. S., Lanes, S. F., Wentworth, C. E., III, et al. (1999, June 14). A metaregression analysis of the dose-response effect of aspirin on stroke. Archives of Internal Medicine, 159(11), 1248-1253. \n" }, { "type": "citation", "citation": "CITATION - Kennedy, J., Hill, M. D., Ryckborst, K. J., et al. (2007, November). Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): A randomised controlled pilot trial. Lancet Neurology, 6(11): 961-969. \n" }, { "type": "citation", "citation": "CITATION - Kernan, W. N., Ovbiagele, B., Black, H. R., et al. (2014, May). Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for health care professionals from the American Heart Association/American Stroke Association. Stroke, 45(7), 2160-2223. \n" }, { "type": "citation", "citation": "CITATION - Powers, W. J., Rabinstein, A. A., Ackerson, T., et al. (2018, January). 2018 guidelines for the early management of patients with acute ischemic stroke: A guideline for health care professionals from the American Heart Association/American Stroke Association. Stroke, 49, e45-e46. \n" }, { "type": "citation", "citation": "CITATION - Roger, V. L., Go, A. S., Lloyd-Jones, D. M., et al. (2012, January 3). Heart disease and stroke statistics—2012 update: A report from the American Heart Association. Circulation, 125(1), e2-e220. \n" }, { "type": "citation", "citation": "CITATION - Sacco, R. L., Diener, H. C., Yusuf, S., et al. (2008, September 18). Aspirin and Extended-Release Dipyridamole Versus Clopidogrel for Recurrent Stroke. New England Journal of Medicine, 359(12), 1238-1251. \n" }, { "type": "citation", "citation": "CITATION - SALT Collaborative Group. (1991, November 30). Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet, 338(8779), 1345-1349. \n" }, { "type": "citation", "citation": "CITATION - UK-Tia Study Group. (1988, January 30). United Kingdom Transient Ischaemic Attack (UK-Tia) Aspirin Trial: Interim results. British Medical Journal (Clinical Research Ed.), 296(6618), 316-320. \n" }, { "type": "citation", "citation": "CITATION - Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., ... Williams, L. S. (2021). 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline from the American Heart Association/American Stroke Association. Stroke, 52(7), e364-e467. https://doi.org/10.1161/STR.0000000000000375\n" } ], "library": [ "https://madie.cms.gov/Library/CMS104FHIRSTKDCAntithrombotic" ], "disclaimer": "These performance measures are not clinical guidelines, do not establish a standard of medical care, and have not been tested for all potential applications. The measures and specifications are provided without warranty.", "rationale": "The effectiveness of antithrombotic agents in reducing stroke mortality, stroke-related morbidity and recurrence rates has been studied in several large clinical trials. While the use of these agents for patients with acute ischemic stroke and transient ischemic attacks continues to be the subject of study, substantial evidence is available from completed studies. Data at this time suggest that antithrombotic therapy should be prescribed at discharge following acute ischemic stroke to reduce stroke mortality and morbidity if no contraindications exist.\n\n\nFor patients with a stroke due to a cardioembolic source (e.g., atrial fibrillation, mechanical heart valve), warfarin is recommended unless contraindicated. In recent years, novel oral anticoagulant agents (NOACs) have been developed and approved by the U.S. Food and Drug Administration (FDA) for stroke prevention and may be considered as an alternative to warfarin for select patients. Anticoagulation therapy is not generally recommended for secondary stroke prevention in patients presumed to have a non-cardioembolic stroke\n\n\nAnticoagulants at doses to prevent venous thromboembolism are insufficient antithrombotic therapy to prevent recurrent ischemic stroke or transient ischemic attack (TIA).", "clinicalRecommendationStatement": "Clinical trial results suggest that antithrombotic therapy should be prescribed at discharge following acute ischemic stroke to reduce stroke mortality and morbidity if no contraindications exist", "group": [ { "id": "Group_1", "extension": [ { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-scoring", "valueCodeableConcept": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-scoring", "code": "proportion", "display": "Proportion" } ] } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-populationBasis", "valueCode": "Encounter" }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-type", "valueCodeableConcept": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-type", "code": "process", "display": "Process" } ] } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-rateAggregation", "valueCode": "None" }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-improvementNotation", "valueCodeableConcept": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-improvement-notation", "code": "increase", "display": "Increased score indicates improvement" } ] } } ], "description": "Ischemic stroke patients prescribed or continuing to take antithrombotic therapy at hospital discharge", "population": [ { "id": "InitialPopulation_1", "code": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-population", "code": "initial-population", "display": "Initial Population" } ] }, "description": "Inpatient hospitalizations (non-elective admissions) for patients age 18 and older, discharged from inpatient care with a principal diagnosis of ischemic stroke, ending during the measurement period", "criteria": { "language": "text/cql-identifier", "expression": "Initial Population" } }, { "id": "Denominator_1", "code": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-population", "code": "denominator", "display": "Denominator" } ] }, "description": "Equals Initial Population", "criteria": { "language": "text/cql-identifier", "expression": "Denominator" } }, { "id": "DenominatorExclusion_1", "code": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-population", "code": "denominator-exclusion", "display": "Denominator Exclusion" } ] }, "description": "- Inpatient hospitalizations for patients admitted for elective carotid intervention. This exclusion is implicitly modeled by only including non-elective hospitalizations.\n- Inpatient hospitalizations for patients discharged to another hospital\n- Inpatient hospitalizations for patients who left against medical advice\n- Inpatient hospitalizations for patients who expired\n- Inpatient hospitalizations for patients discharged to home for hospice care\n- Inpatient hospitalizations for patients discharged to a health care facility for hospice care\n- Inpatient hospitalizations for patients with comfort measures documented", "criteria": { "language": "text/cql-identifier", "expression": "Denominator Exclusions" } }, { "id": "Numerator_1", "code": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-population", "code": "numerator", "display": "Numerator" } ] }, "description": "Inpatient hospitalizations for patients prescribed or continuing to take antithrombotic therapy at hospital discharge", "criteria": { "language": "text/cql-identifier", "expression": "Numerator" } }, { "id": "DenominatorException_1", "code": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-population", "code": "denominator-exception", "display": "Denominator Exception" } ] }, "description": "- Inpatient hospitalizations for patients with a documented reason for not prescribing antithrombotic therapy at discharge\n- Inpatient hospitalizations for patients who receive Prasugrel as an antithrombotic therapy at discharge", "criteria": { "language": "text/cql-identifier", "expression": "Denominator Exceptions" } } ] } ], "supplementalData": [ { "id": "sde-ethnicity", "usage": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-data-usage", "code": "supplemental-data" } ] } ], "description": "SDE Ethnicity", "criteria": { "language": "text/cql-identifier", "expression": "SDE Ethnicity" } }, { "id": "sde-payer", "usage": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-data-usage", "code": "supplemental-data" } ] } ], "description": "SDE Payer", "criteria": { "language": "text/cql-identifier", "expression": "SDE Payer" } }, { "id": "sde-race", "usage": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-data-usage", "code": "supplemental-data" } ] } ], "description": "SDE Race", "criteria": { "language": "text/cql-identifier", "expression": "SDE Race" } }, { "id": "sde-sex", "usage": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-data-usage", "code": "supplemental-data" } ] } ], "description": "SDE Sex", "criteria": { "language": "text/cql-identifier", "expression": "SDE Sex" } } ] }